Proxim Diagnostics & Landrich Group: Paving the Way for PoC Diagnostics
- Jun 11
- 1 min read
This milestone reflects the importance of collaboration and regulatory excellence in advancing innovative point-of-care diagnostics. We are proud to have supported Proxim Diagnostics in its continued development journey, including its strategic investment from bioMérieux, a world leader in in vitro diagnostics.
The investment supports further development of Proxim’s Profile System, a handheld, fully automated immunodiagnostic platform designed to deliver laboratory-quality performance at the point of care using multiplexed assays and disposable cartridges. The platform targets applications in sepsis, cardiology, and infectious disease across emergency departments, ICUs, remote clinics, and in-home care settings, and is currently available for research use only.
At Landrich Group, we support diagnostic and life science innovators through Clinical, Quality, Regulatory, and GxP consulting services, including SOP Development and GCP&GMP Training, helping accelerate development from innovation to commercialization.
If you would like to learn more about our services or discuss your project needs, please
contact us at: admin@landrichgroup.com
